TSXV:BTI.H - Post by User
Comment by
JDavenporton Apr 21, 2022 3:51pm
125 Views
Post# 34621619
RE:RE:trying to understand?
RE:RE:trying to understand?Pof's post is myopic. It's all negative. Bioasis is doing all of its work with partners. Partners have the resources to get things done. But they can only do so much before they'll have to pay Bioasis in a substantial deal.
Vaccinex was worthless. J&J would never announce a deal like this one with Bioasis. It's not material for such a large company. Prothena likely didn't have a payload worth advancing. I believe there's more to the Chiesi deal than 4 LSDs. MedImmune, who claimed that xB3 was the best transport they tested, was subsumed by AstraZeneca. AstraZeneca is in partnership with Daiichi Sankyo. It's unlikely that Daiichi Sankyo would partner with Bioasis on anything if there was a bad word from AstraZeneca. And Bioasis still has access to the Lind LOC. $7 million. That LOC was arranged to give Bioasis leverage in dealmaking. Since it was arranged, Bioasis has developed even more leverage in dealmaking by adding to its list of partners.
As I see it, everything is moving in the right direction. Pof's post is nonsense. I really hope he argues the point.
jd